Literature DB >> 19837767

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Hossein Jadvar1, Abass Alavi, Sanjiv S Gambhir.   

Abstract

It is hoped that in the not too distant future, noninvasive imaging-based molecular interrogation and characterization of tumors can improve our fundamental understanding of the dynamic biologic behavior of cancer. For example, the new dimension of diagnostic information that is provided by (18)F-FDG PET has led to improved clinical decision making and management changes in a substantial number of patients with cancer. In this context, the aim of this review is to bring together and summarize the current data on the correlation between the underlying molecular biology and the clinical observations of tumor (18)F-FDG accumulation in 3 major human cancers: lung, breast, and colon.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19837767      PMCID： PMC2783751          DOI： 10.2967/jnumed.108.054098

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  99 in total

1.  Molecualr imaging of cancer: from molecules to humans. Introduction.

Authors:  Sanjiv Sam Gambhir
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

Review 2.  Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.

Authors:  Sandip Basu; Abass Alavi
Journal:  J Nucl Med       Date:  2008-10       Impact factor: 10.057

Review 3.  Tumor cell metabolism imaging.

Authors:  Christian Plathow; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

4.  Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.

Authors:  Daisuke Uesaka; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Masato Sasaki; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

5.  PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer.

Authors:  Koichi Nagata; Yoshiko Ota; Tomohiko Okawa; Shungo Endo; Shin-ei Kudo
Journal:  Dis Colon Rectum       Date:  2008-03-11       Impact factor: 4.585

6.  Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.

Authors:  S Basu; J Kung; M Houseni; H Zhuang; G F Tidmarsh; A Alavi
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-03-12       Impact factor: 2.346

Review 7.  Causes and consequences of increased glucose metabolism of cancers.

Authors:  Robert J Gillies; Ian Robey; Robert A Gatenby
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

8.  Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

Authors:  Shigeto Ueda; Hitoshi Tsuda; Hideki Asakawa; Takashi Shigekawa; Kazuhiko Fukatsu; Nobuo Kondo; Mikio Yamamoto; Yukihiro Hama; Katsumi Tamura; Jiro Ishida; Yoshiyuki Abe; Hidetaka Mochizuki
Journal:  Jpn J Clin Oncol       Date:  2008-04       Impact factor: 3.019

9.  Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.

Authors:  Ludwig G Strauss; Dirk Koczan; Sven Klippel; Leyun Pan; Caixia Cheng; Stefan Willis; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

10.  Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.

Authors:  Yoo Sung Song; Won Woo Lee; Jin-Haeng Chung; So Yeon Park; Yu Kyeong Kim; Sang Eun Kim
Journal:  Lung Cancer       Date:  2008-01-08       Impact factor: 5.705
View more
  83 in total

Review 1.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

2.  Nuclear medicine, scientific publishing and the era of cost containment: what factors hold the key?

Authors:  Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-14       Impact factor: 9.236

3.  Relationship between the expression of PD-1/PD-L1 and 18F-FDG uptake in bladder cancer.

Authors:  Ruohua Chen; Xiang Zhou; Jianjun Liu; Gang Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-09       Impact factor: 9.236

Review 4.  Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.

Authors:  Ana F Brito; Mónica Mendes; Ana M Abrantes; José G Tralhão; Maria F Botelho
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

5.  18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.

Authors:  Nicolaos Palaskas; Steven M Larson; Nikolaus Schultz; Evangelia Komisopoulou; Justin Wong; Dan Rohle; Carl Campos; Nicolas Yannuzzi; Joseph R Osborne; Irina Linkov; Edward R Kastenhuber; Richard Taschereau; Seema B Plaisier; Chris Tran; Adriana Heguy; Hong Wu; Chris Sander; Michael E Phelps; Cameron Brennan; Elisa Port; Jason T Huse; Thomas G Graeber; Ingo K Mellinghoff
Journal:  Cancer Res       Date:  2011-06-06       Impact factor: 12.701

6.  In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model.

Authors:  Murali K Ravoori; Sheela P Singh; Jaehyuk Lee; James A Bankson; Vikas Kundra
Journal:  Radiology       Date:  2017-07-13       Impact factor: 11.105

7.  Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.

Authors:  He N Xu; Stephen Kadlececk; Harrilla Profka; Jerry D Glickson; Rahim Rizi; Lin Z Li
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

8.  18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.

Authors:  Hye Ryoung Koo; Jeong Seon Park; Keon Wook Kang; Nariya Cho; Jung Min Chang; Min Sun Bae; Won Hwa Kim; Su Hyun Lee; Mi Young Kim; Jin You Kim; Mirinae Seo; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2013-10-05       Impact factor: 5.315

9.  Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

Authors:  Lucía Graña-López; Michel Herranz; Inés Domínguez-Prado; Sonia Argibay; Ángeles Villares; Manuel Vázquez-Caruncho
Journal:  Eur Radiol       Date:  2019-08-02       Impact factor: 5.315

10.  Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.

Authors:  Anne K Due; Ivan R Vogelius; Marianne C Aznar; Søren M Bentzen; Anne K Berthelsen; Stine S Korreman; Annika Loft; Claus A Kristensen; Lena Specht
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.